Cenupatide
Cenupatide (UPARANT) is a Urokinase-type plasminogen activator receptor (uPAR) inhibitor. Cenupatide has anti-angiogenic and anti-inflammatory efficacy[1].
Product Specifications
CAS Number
1006388-38-0
UNSPSC
12352209
Target
Transmembrane Glycoprotein
Type
Peptides
Related Pathways
Immunology/Inflammation
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cenupatide.html
Purity
99.62
Solubility
DMSO : 100 mg/mL (ultrasonic) |H2O : ≥ 100 mg/mL
Smiles
N=C(N)NCCC[C@H](NC(C)=O)C(NC(C)(C)C(N[C@@H](CCCNC(N)=N)C(N[C@@](C(N)=O)(C)CC1=CC=CC=C1)=O)=O)=O
Molecular Formula
C28H47N11O5
Molecular Weight
617.74
References & Citations
[1]Filippo Locri, et al. UPARANT is an effective antiangiogenic agent in a mouse model of rubeosis iridis. J Mol Med (Berl) . 2019, 97, 9.|[2]Cai Yuan, et al. Development of inhibitors for uPAR: blocking the interaction of uPAR with its partners. Drug Discov Today. 2021, 26, 4.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Scientific Category
Peptides
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
